Показати скорочений опис матеріалу
| dc.contributor.author | Obertynska, O | |
| dc.date.accessioned | 2025-12-07T09:19:20Z | |
| dc.date.available | 2025-12-07T09:19:20Z | |
| dc.date.issued | 2025 | |
| dc.identifier.citation | Obertynska O. The impact of a chronic obstructive pulmonary disease diagnosis on the identification of heart failure / O. Obertynska, L. Rasputina, A. Solomonchuk // European Heart Journal. – 2025. – № 46. – P. 1453. – ESC Congress (Madrid, 29 August – 01 September 2025) | uk_UA |
| dc.identifier.issn | ISSN 0195-668X | |
| dc.identifier.uri | https://dspace.vnmu.edu.ua/123456789/10949 | |
| dc.description.abstract | The prevalence of unrecognized HF in symptomatic COPD patients turned out to be 20 %, particularly in severe stages (GOLD 3or 4) underscores the need for routine cardiac evaluation in this population. NT-proBNP levels can be unexpectedly higher in COPD patients due to right ventricular strain and pulmonary hypertension, in the absence of left-sided heart failure making echocardiography essential for accurate diagnosis. Among patients with COPD, HF with preserved EF is the most common. The higher mMRC grade (≥3), older age, obesity, E/e' ratio (>13,5) predict hidden HF in COPD with persistent symptoms despite optimal COPD treatment | uk_UA |
| dc.language.iso | en | uk_UA |
| dc.publisher | European Heart Journal | uk_UA |
| dc.subject | Heart failure, chronic obstructive pulmonary disease, diagnosis Серцева недостатність, хронічне обструктивне захворювання легень, діагностика | uk_UA |
| dc.title | The impact of a chronic obstructive pulmonary disease diagnosis on the identification of heart failure | uk_UA |